Your browser doesn't support javascript.
loading
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
Perales, Miguel-Angel; Ceberio, Izaskun; Armand, Philippe; Burns, Linda J; Chen, Robert; Cole, Peter D; Evens, Andrew M; Laport, Ginna G; Moskowitz, Craig H; Popat, Uday; Reddy, Nishitha M; Shea, Thomas C; Vose, Julie M; Schriber, Jeffrey; Savani, Bipin N; Carpenter, Paul A.
Afiliación
  • Perales MA; Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address: peralesm@mskcc.org.
  • Ceberio I; Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Hematology Department, Hospital Universitario Donostia, Donostia, Spain.
  • Armand P; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Burns LJ; Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.
  • Chen R; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California.
  • Cole PD; Department of Pediatrics, Albert Einstein College of Medicine and Department of Pediatric Hematology/Oncology, The Children's Hospital at Montefiore, Bronx, New York.
  • Evens AM; Department of Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts.
  • Laport GG; Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, California.
  • Moskowitz CH; Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Reddy NM; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shea TC; Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.
  • Vose JM; Division of Hematology/Oncology, The Nebraska Medical Center, Omaha, Nebraska.
  • Schriber J; Cancer Transplant Institute, Virginia G Piper Cancer Center, Scottsdale, Arizona.
  • Savani BN; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Biol Blood Marrow Transplant ; 21(6): 971-83, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25773017
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre Hematopoyéticas / Agonistas Mieloablativos / Enfermedad Injerto contra Huésped Tipo de estudio: Guideline Límite: Adult / Child / Humans Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre Hematopoyéticas / Agonistas Mieloablativos / Enfermedad Injerto contra Huésped Tipo de estudio: Guideline Límite: Adult / Child / Humans Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2015 Tipo del documento: Article